Charlie Lowrey
Analyst · Jefferies
So, I would say, yes, to both of those. So, let me go through yes and, Suneet. So first, I’ll go through each one sort of GUL and then the VA business. But, first, we are very pleased with the valuation we received for reinsuring the $12.5 billion block of guaranteed universal life policies that we announced last week. And as we said, we expect to receive approximately $450 million of proceeds when the transaction closes. The transaction will be accretive to earnings and will also reduce our market sensitivity and increase our capital flexibility. But would we consider an additional de-risking opportunity for Life sub block? Absolutely. As long as it met the strategic financial objectives and made sense to all our stakeholders. However, we’re going to be disciplined in our approach as the individual life business continues to be core to our purpose. There’s still significant potential for growth in the industry with a $12 trillion life insurance gap. And I think our strong Individual Life sales in the second quarter reflects our product pivot to less market-sensitive products. And from an enterprise perspective, our Life business helps balance our longevity with our mortality, so it remains important to us. On the VA side, it’s a little bit of a different story, but there are some similarities. So we’ve made considerable progress in reducing the market sensitivity and increasing our capital flexibility through the two transactions we’ve done, and we’re pleased with the valuations, again, that we received for reinsuring the $10 billion block of traditional variable annuities in the second quarter as well as the valuation for the $30 billion block we sold last year. But as a result of these transactions, as we’ve said, and the natural runoff of this business, we have achieved the original objective that we established two years ago of blowing the proportion of traditional variable annuities. So, we’re not in a position of having to do another transaction. Having said that, I want to be very clear that we’ll continue to explore additional opportunities. But again, to state the obvious, but I’ll state it, we’ll only do something if it’s in the best interest of all our stakeholders. But these transactions aren’t only about de-risking. As you said, they’re also about growth. So, while we’ve been quite successful in our de-risking efforts as part of our strategy, we’ve also been equally focused on growing with less market-sensitive products in our businesses, which you’ve seen over the past few quarters. So, let me turn it over to Caroline for a minute because -- Caroline, would you want to talk about some of the progress we’ve made with that part of our strategy?